Stratified analyses showed a significant inverse relationship between T2DM and Her2 expression in studies recruiting populations with a median calendar year of breast cancer diagnosis ≤2008, which might be intertwined by different Her2 testings with error rates [82]. Here, ERBB2 is linked to breast cancer.